MedPath

TECARTUS

TECARTUS

Approved
DIN Number

02516667

Drug Class

Human

Market Date

Dec 16, 2021

Company
HC

gilead sciences canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02516667
AIG Number0162968001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L01XL06 BREXUCABTAGENE AUTOLEUCEL
Product Specifications
Dosage FormSuspension
Route of AdministrationIntravenous
AHFS Classification26:12.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

BREXUCABTAGENE AUTOLEUCELActive
Strength: 200000000 CELLS / BAG
Monograph: BREXUCABTAGENE AUTOLEUCEL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.